Aviragen Therapeutics
Get Full AccessDescription
- Aviragen Therapeutics is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally. The Company has three Phase 2 clinical stage compounds: vapendavir, a capsid inhibitor for the prevention or treatment of rhinovirus (RV) upper respiratory infections; enzaplatovir (BTA585), a fusion protein inhibitor in development for the treatment of respiratory syncytial virus infections; and BTA074, an antiviral treatment for condyloma caused by human papillomavirus types 6 & 11.
-
Headquarters:2500 Northwinds Parkway Suite 100, Alpharetta, Georgia, United States
More -
Phone Number: +1 678-545-4621
-
Website: https://www.aviragentherapeutics.com
-
Employees:38
-
Revenue:$10 - 50M
-
Legal Name:Aviragen Therapeutics
-
Aviragen Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 0 |
Show More
Frequently Asked Questions regarding Aviragen Therapeutics
-
Where are Aviragen Therapeutics's Headquarters?
Aviragen Therapeutics's Headquarters are in 2500 Northwinds Parkway Suite 100,Alpharetta,Georgia,United States
-
What is Aviragen Therapeutics's phone number?
Aviragen Therapeutics's phone number is +1 678-545-4621
-
What is Aviragen Therapeutics's official website?
Aviragen Therapeutics's official website is https://www.aviragentherapeutics.com
-
What is Aviragen Therapeutics's Revenue?
Aviragen Therapeutics's revenue is $10 - 50M
-
How many employees are working in Aviragen Therapeutics
Aviragen Therapeutics has 38 employees
-
What is Aviragen Therapeutics's Industry?
Aviragen Therapeutics is in the industry of Research
-
Who is Aviragen Therapeutics's CEO?
Aviragen Therapeutics's CEO is Peter Cook
-
Who is Aviragen Therapeutics's Vice President Corporate Development And Strategy?
Aviragen Therapeutics's Vice President Corporate Development And Strategy is Jonas Niaura

